Florida Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.

Press releases published on September 18, 2026

Sep. 18, 2026

DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Shares

Indeterminate EIN Presswire

Sep. 18, 2026

Refresh Examines How AI and Healthy Aging Are Reshaping Aesthetics in 2026

Indeterminate EIN Presswire

Sep. 18, 2026

JAGUARS’ ‘STADIUM OF THE FUTURE’ SALES CENTER FEATURES THE IMMERSIVE CUBE™ BY ADVENT

Indeterminate EIN Presswire

Sep. 18, 2026

RCO Cash for Cars Expands Direct Automotive Recycling Network Following Nearly 10-Year Peddle Relationship

Indeterminate EIN Presswire

Sep. 18, 2026

Skillable recognized as a six-time Training Industry 2026 Top Experiential Learning Technologies Company 

Indeterminate EIN Presswire

Sep. 18, 2026

Lake Technical College Named 2026 Best of Florida Regional Award Winner

Indeterminate EIN Presswire

Sep. 18, 2026

Government Contractors Invited to Discover How Expert Human Review Transforms AI-Generated Bids

Indeterminate EIN Presswire

Sep. 18, 2026

LawDiver Launches Free Legal Research Platform to Search 10 Million U.S. Court Opinions and Verify Legal Citations

Indeterminate EIN Presswire

Sep. 18, 2026

BIBLIOJAM ANNOUNCES APP THAT TURNS THE ENTIRE BIBLE INTO A YEARLONG MUSICAL EXPERIENCE

Indeterminate GlobeNewswire

Sep. 18, 2026

CT UAV Successfully Designs 230 kg Heavy-Lift Transport UAV, Capable of Carrying 100 kg

Indeterminate GlobeNewswire

Sep. 18, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Bastion Receives Conditional OCC Approval for a National Trust Bank Charter

Indeterminate GlobeNewswire

Sep. 18, 2026

New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

Indeterminate GlobeNewswire

Sep. 18, 2026

Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

Indeterminate GlobeNewswire

Sep. 18, 2026

Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults

Indeterminate GlobeNewswire

Sep. 18, 2026

NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update

Indeterminate GlobeNewswire

Sep. 18, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Amneal Announces FDA Approval and Launch of Lanreotide Injection

Indeterminate GlobeNewswire